AI assistant
Alkermes plc. — Director's Dealing 2011
Sep 21, 2011
31048_dirs_2011-09-21_67601478-d807-4e73-8fef-95172cc8276e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: Alkermes plc. (ALKS)
CIK: 0001520262
Period of Report: 2011-09-16
Reporting Person: SKALETSKY MARK B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-09-16 | Common Stock | D | 5000 | — | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $14.49 | D | 24000 | Disposed | 2014-06-01 | Common Stock (24000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $11.84 | D | 15000 | Disposed | 2014-09-23 | Common Stock (15000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $16.77 | D | 20000 | Disposed | 2015-09-23 | Common Stock (20000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $14.04 | D | 20000 | Disposed | 2016-09-21 | Common Stock (20000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $18.29 | D | 20000 | Disposed | 2017-10-09 | Common Stock (20000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $11.44 | D | 20000 | Disposed | 2018-10-07 | Common Stock (20000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $8.98 | D | 20000 | Disposed | 2019-10-06 | Common Stock (20000) | Direct |
| 2011-09-16 | Non Qualified Stock Option (Right to Buy) | $14.92 | D | 20000 | Disposed | 2020-10-05 | Common Stock (20000) | Direct |
Footnotes
F1: Received in exchange for shares of Alkermes, Inc. common stock in connection with the merger of Alkermes, Inc. and the global drug delivery technologies business of Elan (the "Merger"). On 9/16/11, the effective date of the Merger, the closing price of ALKS was $16.57 per share.
F2: These options are fully vested in accordance with their terms.
F3: Form 4 Amendment being filed to correctly reflect that no price was paid by the reporting person for receipt of these derivative securities by eliminating the price in column 8.
F4: Received in exchange for, and having substantially the same terms as, stock options of Alkermes, Inc. common stock in connection with the Merger.